Clinical Trials Directory

Trials / Unknown

UnknownNCT06119880

The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy

The Effect of PERT on Postoperative Complications and Physiological Status in Patients Undergoing Pancreaticoduodenectomy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A comprehensive perioperative nutrition management plan for pancreaticoduodenectomy, primarily based on pancreatic enzyme replacement therapy (PERT). A prospective randomized controlled study was conducted to comprehensively analyze the perioperative nutritional status of patients undergoing pancreaticoduodenectomy, with the aim of exploring: 1. The effect of PERT on postoperative complications and physiological status after pancreaticoduodenectomy; 2. The efficacy of PERT treatment on clinical symptoms, nutritional indicators, and quality of life (QOL) related to pancreatic exocrine dysfunction (PEI) after pancreaticoduodenectomy; 3. The personalized full process nutrition management strategies based on risk factor stratification.

Conditions

Interventions

TypeNameDescription
DRUGPancreatin Enteric-coated Capsulespancreatic enzyme replacement therapy
OTHERRoutine treatment planRoutine treatment plan without PERT

Timeline

Start date
2023-11-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2023-11-07
Last updated
2023-11-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06119880. Inclusion in this directory is not an endorsement.